Literature DB >> 20828906

A physiologic-based approach to the evaluation of a patient with hypokalemia.

Biff F Palmer1.   

Abstract

Hypokalemia is a common electrolyte disorder. Transient causes of hypokalemia are due to cell shift, whereas sustained hypokalemia is caused by either inadequate intake or excessive potassium loss. Evaluation of the intake, distribution, and excretion of potassium should include the following: (1) a careful history, including use of drugs, medications, and the presence of vomiting or diarrhea; (2) physical examination, including orthostatic changes in blood pressure and heart rate; and (3) measurement of urine and plasma electrolytes. Urinary potassium wasting is caused by pathophysiologic conditions that couple increased distal sodium delivery with increased plasma aldosterone levels or aldosterone-like effects. If urinary potassium loss is identified, the next step is to determine whether the loss is caused by a primary increase in distal delivery of sodium or a primary increase in mineralocorticoid level. A primary increase in distal delivery should be associated with volume depletion, whereas a primary increase in mineralocorticoid level generally is associated with volume expansion and hypertension. In patients with a primary increase in mineralocorticoid activity, it is useful to measure plasma renin activity and plasma aldosterone levels. Complications of hypokalemia include muscle weakness, rhabdomyolysis, cardiac arrhythmias, impaired urinary concentrating ability, and glucose intolerance.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20828906     DOI: 10.1053/j.ajkd.2010.07.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  American Society of Nephrology Quiz and Questionnaire 2013: electrolyte and acid-base.

Authors:  Biff F Palmer; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

2.  Syndromes of Pseudo-Hyperaldosteronism.

Authors:  Katherine Rizzolo; Natalie M Beck; Sophia L Ambruso
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-08       Impact factor: 8.237

3.  A physiologic-based approach to the treatment of a patient with hypokalemia.

Authors:  Abdo Asmar; Rajesh Mohandas; Charles S Wingo
Journal:  Am J Kidney Dis       Date:  2012-09       Impact factor: 8.860

Review 4.  Regulation of Potassium Homeostasis.

Authors:  Biff F Palmer
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

5.  Assessment of ondansetron-associated hypokalemia in pediatric oncology patients.

Authors:  Elsa Fiedrich; Vikram Sabhaney; Justin Lui; Maury Pinsk
Journal:  ISRN Oncol       Date:  2012-09-19

6.  Addison's disease associated with hypokalemia: a case report.

Authors:  M Abdalla; J A Dave; I L Ross
Journal:  J Med Case Rep       Date:  2021-03-25

7.  Late-Onset Hypokalemic Periodic Paralysis in an Adult Female With Type 2 Renal Tubular Acidosis: A Case Report.

Authors:  Vivian C Chukwuedozie; Tulika Garg; Hassan A Chaudhry; Saima H Shawl; Priya Mishra; Ngozi J Adaralegbe; Aadil Khan
Journal:  Cureus       Date:  2022-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.